Curis Inc
CRIS
NASDAQ
Biotechnology
$1.80
USD
-0.07 (-3.74%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.64M
Volume 469.5K
Revenue
$7.06M
TTM
-36.9%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-21.16M
TTM
+49.8%
YoY
Operating Cash Flow
$-28.95M
TTM
+13.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 2.4 | 2.7 | 3.2 | 1.1 | 0.0 |
YoY Growth | +14.1% | +8.0% | +8.4% | -66.0% | -100.0% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 2.4 | 2.7 | 3.2 | 1.1 | 0.0 |
Selling, General & Administrative | 4.0 | 3.5 | 3.7 | 2.9 | 5.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | -27.2 | 0.0 |
Total Operating Expenses | 12.5 | 11.0 | 10.1 | -18.5 | 11.5 |
Operating Income | -10.2 | -8.3 | -6.9 | 19.6 | -11.5 |
EBITDA | -10.1 | -8.2 | -6.9 | 19.7 | -11.5 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | -12.8 |
Total Other Income / Expense | -0.5 | -0.3 | -0.8 | -0.3 | -12.7 |
Income Before Income Taxes | -10.6 | -8.6 | -7.7 | 19.4 | -24.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -10.6 | -8.6 | -7.7 | 19.4 | -24.2 |
Consolidated Net Income / Loss | -10.6 | -8.6 | -7.7 | 19.4 | -24.2 |
Net Income Attributable to Common Shareholders | -10.6 | -8.6 | -7.7 | 19.4 | -24.2 |
Basic EPS | -$25.00 | -$13.60 | -$9.80 | $24.42 | -$25.00 |
Diluted EPS | -$25.00 | -$13.60 | -$9.80 | $24.42 | -$25.00 |
Basic Shares Outstanding | 0.4M | 0.6M | 0.8M | 0.8M | 1.0M |
Diluted Shares Outstanding | 0.4M | 0.6M | 0.8M | 0.8M | 1.0M |